Thu, Jul 24, 2014, 5:37 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Biodel Inc. (BIOD) Message Board

  • failupward failupward May 30, 2013 1:20 PM Flag

    What do you folks think of MNKD?

    No injection mealtime insulin without a tail. Submit (resubmit) to FDA in June. Almost certainty of approval this time. Thoughts?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Looks like the question to ask is, what do you folks think of BIOD!!!

    • If MNKD gets the approval before Biodel, Then Biodel will plunge into $2 to $3 - Big Risk
      If MNKD not gets approval and BIOD gets approval, this will be trading in $20s - Big Charm
      If Biodel gets the approval 1st and then MNKD then also BIODel will be a loser too will be plunge to 6 to 8
      So watch closely before the PDUFA.

    • I wouldn't exactly call MNKD's Afreeza a certainty for approval. The technology is great, but unfortunately for MNKD, inhaled insulin has a stigma to it. WIth that said, the technology is revolutionary. The drug could potentially do sales in the 10s of billions of dollars within 5-10 years if approved. I own the stock, but not as much as BIOD. MNKD has been heavily diluted and really has just one viable drug candidate.

      I prefer BIOD for the reasons abe8_99 mentioned. The managment is better. They haven't bet the house on one drug and have created a decent drug pipeline while at the same time managing their shares/finances extremely well. The stock is undervalued, but that will change over the next 6 months IMHO.

      Sentiment: Buy

    • I hold shares in BOTH companies, and hope both will have FDA approvals, and success with their products.
      MNKD has appreciated 300% since last summer, and more is still to come...

      However, IMHO, the upward move of BIOD's share price could be even more impressive, given the low number of shares, solid finances, zero debt, and how UNDERVALUED it has been in the last 18 months.

      I also believe BIOD could partner or get into a merger/ buyout agreement in the near future , given what a bargain this company is with 4(!!!) promising programs that are advancing nicely , and high reported interest from many potential partners ...

 
BIOD
1.96+0.04(+2.08%)Jul 24 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.